Today in Kabul, the Quamed and Relief International team conducted our Barriers & Solutions Workshop, focused on how to best facilitate local procurement of quality medical products in Afghanistan. Internet was still offline, which impeded registered turnout, but we had vibrant interactive discussions with over 35 external participants, with an even mix between government authorities, ...
A new study highlights the challenges of accessing essential medicines in the South Pacific, with lower-middle-income countries facing the lowest availability (59.1% public, 57.4% private) and significant affordability barriers. While upper-middle and high-income countries show better access, medicine prices remain high across the region. Urgent policy reforms and strategic initiatives are needed to address these ...
At the end of two weeks of stakeholder meetings in Kabul, together with the Relief International team, the Quamed team formally kicked off the Local Medical Supplier Development Project in Afghanistan with the project’s Inception Workshop. The workshop was attended by 50+ delegates, who heard preliminary findings from the market analysis of the local medical ...
QUAMED’s experts have completed a Good Storage and Distribution Practices audit at CAMESKIN ( https://www.cameskin.org/ ) and GSDP technical visits with two private-sector for-profit pharmaceutical wholesalers. They are still in Kinshasa. The picture shows our experts in the CAMESKIN warehouse. Friday one of our experts will be travelling to Goma and visit Asrames (www.asrames.org) and the ...
For our francophone colleagues. Please read the article by Jean van Wetter, Executive Director of Enabel. On important issues such as access and quality in the Covid-19 era with reference to DRC, ITM and QUAMED: https://lnkd.in/dUDxXgy
The European Public Health Alliance organises a series of online discussions on key access to medicines (A2M) priorities bringing together thought leaders and policy-makers, academics, industry representatives and NGOs, for a frank discussion of European pharmaceutical policies. The next one is on the 8th of December. The topic is: “Will the EU be a wise ...
The European Commission is organising a #covid meeting on vaccines: https://www.ema.europa.eu/en/events/public-stakeholder-meeting-development-authorisation-safe-effective-covid-19-vaccines-eu Their event summary: “EMA is organising this virtual meeting to explain the processes for the development, evaluation, approval and safety monitoring of COVID-19 vaccines in the EU, including EMA’s specific role, to all interested parties. It will also give the opportunity to the public and ...
In June 2021, the Institute of Tropical Medicine in Antwerp will host a new short course (3-weeks) on Pharmaceutical Policies in Health Systems. It targets students from high-, middle- and low-income countries working at different levels in the Ministry of Health, health programmes, regulatory agencies, NGOs, global health initiatives and other donor agencies, etc. Importantly, the ...
Toolkit for Businesses & Workplaces Interesting and useful guidance and tools are available on the CDC website to make workplaces and businesses safer in regard to Covid-19. https://www.cdc.gov/coronavirus/2019-ncov/communication/toolkits/business-workplaces.html?ACSTrackingID=SCDC_2067-DM41308&ACSTrackingLabel=Toolkit%20for%20Youth%20Sports%20%7C%20COVID-19&deliveryName=SCDC_2067-DM41308
WHO AFRO Regional Office report on their rapid assessment of the the national regulatory systems in the Southern African Development Community in the Journal of Pharmaceutical Policy and Practice. It can be downloaded from the JPPP site (open access) by clicking on the title of the article: “A rapid assessment of the National Regulatory Systems ...
Would you like more information about audits or get a quote? Do not hesitate to contact us via the contact form.
En poursuivant votre visite sur ce site, vous acceptez l'utilisation de cookies En savoir plus
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.